ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.49
0.55%
US Tech 100
20,689.20
0.52%
S&P 500
5,956.06
0.01%
US Dollar vs CAD
1.43283
-0.07%
Bitcoin
85,907.10
2.20%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Omeros Corporation (OMER) Share Price

Omeros Corporation

Omeros Corporation (OMER)

Omer Spa
8.75
0.30
(3.55%)
Closed February 26 3:00PM
Delayed by 15 minutes
8.75
0.00
( 0.00% )
Pre Market: 3:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.75
Bid
8.02
Ask
9.45
Volume
-
0.00 Day's Range 0.00
2.612 52 Week Range 13.60
Market Cap
507.06M
Previous Close
8.75
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
738,435
Shares Outstanding
57,949,760
Dividend Yield
-
PE Ratio
-4.30
Earnings Per Share (EPS)
-2.03
Revenue
-
Net Profit
-117.81M

About Omeros Corporation

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injec... Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.omeros.com
Headquarters
Tumwater, Washington, USA
Founded
-
Omeros Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OMER. The last closing price for Omeros was US$8.75. Over the last year, Omeros shares have traded in a share price range of US$ 2.612 to US$ 13.60.

Omeros currently has 57,949,760 shares outstanding. The market capitalization of Omeros is US$507.06 million. Omeros has a price to earnings ratio (PE ratio) of -4.30.

Ask ADVFN Intelligence (AI)

Omeros (OMER) Options Flow Summary

OMER Options Flow

Overall Flow

Bearish

Net Premium

-29k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

OMER Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 20 2025
OMER (3.55%)

Form 8-K - Current report
Edgar (US Regulatory)
January 16 2025
OMER (3.55%)

Form 8-K - Current report
Edgar (US Regulatory)
December 19 2024
OMER (3.55%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.79-8.280922431879.5410.038.296492398.92889194CS
40.050.5747126436788.710.038.254592368.92597848CS
12-2.87-24.698795180711.6213.67.27384359.51882275CS
264.67114.4607843144.0813.63.547153678.41206606CS
524.0686.56716417914.6913.62.6125437936.89873004CS
1561.6122.54901960787.1413.60.926960514.64892419CS
260-3.91-30.884676145312.6625.490.927739788.45426972CS

OMER - Frequently Asked Questions (FAQ)

What is the current Omeros share price?
The current share price of Omeros is US$ 8.75
How many Omeros shares are in issue?
Omeros has 57,949,760 shares in issue
What is the market cap of Omeros?
The market capitalisation of Omeros is USD 507.06M
What is the 1 year trading range for Omeros share price?
Omeros has traded in the range of US$ 2.612 to US$ 13.60 during the past year
What is the PE ratio of Omeros?
The price to earnings ratio of Omeros is -4.3
What is the reporting currency for Omeros?
Omeros reports financial results in USD
What is the latest annual profit for Omeros?
The latest annual profit of Omeros is USD -117.81M
What is the registered address of Omeros?
The registered address for Omeros is 3400 CAPITOL BLVD SE, TUMWATER, WASHINGTON, 98501
What is the Omeros website address?
The website address for Omeros is www.omeros.com
Which industry sector does Omeros operate in?
Omeros operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TRIThomson Reuters Corporation
US$ 179.88
(798.05%)
254
ULYUrgent ly Inc
US$ 0.8804
(109.62%)
1.42M
VMARVision Marine Technologies Inc
US$ 1.26
(72.37%)
2.43M
CPOPPop Culture Group Company Ltd
US$ 1.12
(61.85%)
809.01k
ICCTiCoreConnect Inc
US$ 1.60
(46.79%)
17.36k
SYTASiyata Mobile Inc
US$ 3.12
(-25.18%)
7.19k
PITAHeramba Electric PLC
US$ 0.5319
(-22.75%)
34.84k
ELVNEnliven Therapeutics Inc
US$ 16.00
(-21.10%)
6
BTOGBit Origin Ltd
US$ 0.1903
(-19.30%)
25.56k
FWRDForward Air Corporation
US$ 21.12
(-17.98%)
103
VMARVision Marine Technologies Inc
US$ 1.26
(72.37%)
2.43M
ULYUrgent ly Inc
US$ 0.8804
(109.62%)
1.42M
CPOPPop Culture Group Company Ltd
US$ 1.12
(61.85%)
809.01k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13.46
(1.28%)
650.69k
NIXXNixxy Inc
US$ 2.145
(35.76%)
611.95k

OMER Discussion

View Posts
glenn1919 glenn1919 3 months ago
omer................................nice miss.................................
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
OMER MONSTER PLAY OF THE DAY
👍️0
Monksdream Monksdream 1 year ago
OMER new 52=week low
Then bounce
👍️0
shurtha2000 shurtha2000 1 year ago
$341M cash and $12M recievables
👍️0
starkd748 starkd748 2 years ago
Gap filled 6s 7s next top
👍️0
Roadtojourney Roadtojourney 2 years ago
With the type of news this should have been above 5 not sure whats wrong here?
👍️0
starkd748 starkd748 2 years ago
3.20 gap must fill now
👍️0
TheFinalCD TheFinalCD 2 years ago
OMER $200M PAYMENT
👍️0
makinezmoney makinezmoney 2 years ago
$OMER: She back on fire now............ sheeeshhhhhhhhhhhhhh


Go baby goooooooooo.......... $3 breaker upside




GO $OMER
👍️0
starkd748 starkd748 2 years ago
Weeeeeeee
👍️0
starkd748 starkd748 2 years ago
We get some 5s I'm backing up the truck
👍️0
starkd748 starkd748 3 years ago
Was a good trade but it's been done since 7s
👍️0
starkd748 starkd748 3 years ago
Weeeeee
👍️0
starkd748 starkd748 3 years ago
Weeeeeeeeeeeee
👍️0
starkd748 starkd748 3 years ago
Yesss
👍️0
starkd748 starkd748 3 years ago
Looking good
👍️0
starkd748 starkd748 3 years ago
Weeeeee
👍️0
starkd748 starkd748 3 years ago
Yesss
👍️0
starkd748 starkd748 3 years ago
Bounced off the low 3s time to load
👍️0
starkd748 starkd748 3 years ago
Maybe an A B C ... 2.17 might coming
👍️0
starkd748 starkd748 3 years ago
Not ready yet
👍️0
starkd748 starkd748 3 years ago
I like this at a certain fib level hehehe
👍️0
bandit007 bandit007 3 years ago
Great day here! $OMER
👍️0
bandit007 bandit007 3 years ago
Breaking out!
👍️0
bandit007 bandit007 3 years ago
Looking good here. Steady climb
👍️0
bandit007 bandit007 3 years ago
Looking good here. Steady climb
👍️0
Scott 75 Scott 75 3 years ago
Wow! Thanks for sharing. I can't believe with all that going for it and the price is so beaten down.
👍️0
Nefyn Nefyn 3 years ago
So what happens to OMER…a public company with tons of cash and no business operations?
👍️0
JackAskSlap JackAskSlap 3 years ago
Bahhh Bahhh

gonna do this all day long
👍️0
JackAskSlap JackAskSlap 3 years ago
another round for the apes Lets GO !!
👍️0
JackAskSlap JackAskSlap 3 years ago
Glad I'm just a robot no emotions needed
👍️0
JackAskSlap JackAskSlap 3 years ago
Fk with BB My new addiction
👍️0
JackAskSlap JackAskSlap 3 years ago
IN now I'm gonna tick flip this POS to death
👍️0
JackAskSlap JackAskSlap 3 years ago
Trying for the baseline
no holds barred..
👍️0
Jess070283 Jess070283 3 years ago
Load it up!$$$
👍️0
TheGreenReaper TheGreenReaper 3 years ago
OMER$$$$
👍️0
Golden Cross Golden Cross 3 years ago
$14 Targeting
👍️0
crudeoil24 crudeoil24 3 years ago
59M trading float. Huge news out >
👍️0
crudeoil24 crudeoil24 3 years ago
Shorts feeling the heat!!!!! >
👍️0
crudeoil24 crudeoil24 3 years ago
>>>>> GANGBUSTERS <<<<< $$$$$

OMER
👍️0
crudeoil24 crudeoil24 3 years ago
OMER > That is a sweet revenue deal. OMER heading to $20.00+
$125 million upfront payment and $200 million on achievement of commercial milestone
Royalties of 50% on U.S. net sales until the earlier of either January 1, 2025 or payment of the $200-million milestone, after which royalties adjust to 30% of U.S. net sales
Royalties of 15% on ex-U.S. net sales
OMIDRIA to become a premier product in Rayner’s ophthalmology franchise
In addition to acquiring the OMIDRIA commercial organization, including the current OMIDRIA sales force, Rayner plans to further expand its U.S. and ex-U.S. sales forces
👍️0
TheFinalCD TheFinalCD 3 years ago
https://ih.advfn.com/stock-market/NASDAQ/omeros-OMER/stock-news/86711139/omeros-announces-agreement-to-sell-omidria-franch
👍️0
Frankestin Frankestin 3 years ago
Here are the 5!
Very interesting if it goes under!
I would be tempted to open the position now!
👍️0
Frankestin Frankestin 3 years ago
Someone says 5 ... will it get there?
I would like to enter but of course they spend a lot on research and development... and for sell
👍️0
Frankestin Frankestin 3 years ago
ooOOoo
I take a handful these days!
👍️0
Termite7 Termite7 3 years ago
Buying opportunity???
👍️0
frugalNorwegian frugalNorwegian 4 years ago
I created a page on my site talking about OMER. Let me know if I am missing any nuggets. Thanks.

https://frugalnorwegian.com/omer

Summary: This company is a prime candidate for a buyout if FDA approval is given.
👍️0
Dr_Thorfin Dr_Thorfin 4 years ago
If one is worried about fda's delay, Check out @alanrobertross message on StockTwits http://stocktwits.com/alanrobertross/message/333077805
👍️0
umiak umiak 4 years ago
Tute ownership up to 78% been hovering around 50% for years. 20% short
👍️0
umiak umiak 4 years ago
Not new news but I like the smart reporting style:
Omeros's Biologics License Application for Blood Vessel Damage Treatment Candidate Accepted for Priority Review by FDA

1/19/21, 8:06 AM
10:06 AM EST, 01/19/2021 (MT Newswires) -- Omeros (OMER) said Tuesday its biologics license application for narsoplimab, a potential treatment for transplant-associated thrombotic microangiopathy, has been accepted for priority review by the US Food and Drug Administration.

Thrombotic microangiopathy is characterized by a pattern of damage in the small blood vessels.

The FDA has set the Prescription Drug User Fee Act action date on July 17.
👍️0

Your Recent History

NASDAQ
OMER
Omeros
COIN
PROMISEUSD
Promise
TG
0C6
CarGurus
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads